Electrospray ionization(ESI) and tandem mass spectrometry have been used to investigate the gas phase interactions of five metal ions and seven dipeptides. For silver ion, two complexes( + and +) were obtained as well...Electrospray ionization(ESI) and tandem mass spectrometry have been used to investigate the gas phase interactions of five metal ions and seven dipeptides. For silver ion, two complexes( + and +) were obtained as well as the one complex ( +) for transition metal ions. Upon collision activation, there is an obvious difference in MS/MS data between metal ion complex and the protonated molecule. The fragment pathway of each complex is related to the structures of dipeptide and the nature of metal ion which suggest that there are several interaction between the metal ions and dipeptides in gas phase.展开更多
目的:探讨热休克蛋白-抗原肽复合物(HSP)疫苗预防肝癌术后复发的效果.方法:回顾性分析32例应用HSP疫苗的原发性肝癌患者,并检测治疗前后T细胞亚群、NK细胞活性和血清IL-2受体水平的变化,计算3 a内的生存率,并与对照组比较.结果:治疗组术...目的:探讨热休克蛋白-抗原肽复合物(HSP)疫苗预防肝癌术后复发的效果.方法:回顾性分析32例应用HSP疫苗的原发性肝癌患者,并检测治疗前后T细胞亚群、NK细胞活性和血清IL-2受体水平的变化,计算3 a内的生存率,并与对照组比较.结果:治疗组术后3 mo CD3+,CD8+,CD4+/CD8+水平与术前和对照组比较有显著性差异(P<0.05),NK细胞活性较治疗前明显升高(P<0.01);治疗组3a生存率为68.8%,与对照组37.5%比较明显升高(P<0.05).结论:肝癌术后应用HSP疫苗能明显提高患者免疫功能,且可预防术后复发、提高远期生存率.展开更多
文摘Electrospray ionization(ESI) and tandem mass spectrometry have been used to investigate the gas phase interactions of five metal ions and seven dipeptides. For silver ion, two complexes( + and +) were obtained as well as the one complex ( +) for transition metal ions. Upon collision activation, there is an obvious difference in MS/MS data between metal ion complex and the protonated molecule. The fragment pathway of each complex is related to the structures of dipeptide and the nature of metal ion which suggest that there are several interaction between the metal ions and dipeptides in gas phase.
文摘目的:探讨热休克蛋白-抗原肽复合物(HSP)疫苗预防肝癌术后复发的效果.方法:回顾性分析32例应用HSP疫苗的原发性肝癌患者,并检测治疗前后T细胞亚群、NK细胞活性和血清IL-2受体水平的变化,计算3 a内的生存率,并与对照组比较.结果:治疗组术后3 mo CD3+,CD8+,CD4+/CD8+水平与术前和对照组比较有显著性差异(P<0.05),NK细胞活性较治疗前明显升高(P<0.01);治疗组3a生存率为68.8%,与对照组37.5%比较明显升高(P<0.05).结论:肝癌术后应用HSP疫苗能明显提高患者免疫功能,且可预防术后复发、提高远期生存率.
